Virtus ETF Advisers LLC - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 141 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 5.21 and the average weighting 0.4%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$645,000
+125.5%
17,112
+1.8%
0.27%
+128.6%
Q4 2020$286,000
-22.3%
16,810
-38.9%
0.12%
-84.8%
Q1 2019$368,000
+26.0%
27,492
-12.5%
0.78%
+1466.0%
Q4 2018$292,000
-21.7%
31,427
+17.2%
0.05%
+28.2%
Q3 2018$373,000
-48.7%
26,824
-41.7%
0.04%
-93.9%
Q2 2018$727,000
+17.1%
46,007
+27.3%
0.64%
+19.3%
Q1 2018$621,000
+63.0%
36,128
+108.0%
0.54%
+12.8%
Q4 2017$381,000
-15.1%
17,371
+58.4%
0.48%
+683.6%
Q3 2017$449,000
+49.7%
10,966
+10.1%
0.06%
+35.6%
Q2 2017$300,000
+47.8%
9,963
+77.0%
0.04%
+25.0%
Q1 2017$203,000
-20.4%
5,628
+10.6%
0.04%
-52.6%
Q4 2016$255,000
-16.7%
5,088
-12.8%
0.08%
-48.6%
Q3 2016$306,000
+27.0%
5,8370.0%0.15%
-17.3%
Q2 2016$241,000
-6.2%
5,837
-7.7%
0.18%
-49.4%
Q1 2016$257,0006,3210.35%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Eventide Asset Management 601,000$24,587,0001.39%
HealthCor Management, L.P. 1,010,930$41,357,0001.39%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 86,500$3,535,0001.38%
PURA VIDA INVESTMENTS, LLC 75,000$3,068,0000.90%
BB BIOTECH AG 777,500$31,808,0000.88%
AWM Investment Company, Inc. 100,000$4,091,0000.71%
Granite Point Capital Management, L.P. 50,000$2,046,0000.43%
Rock Springs Capital Management LP 217,700$8,906,0000.41%
Crestline Management, LP 50,919$2,083,0000.29%
ADAGE CAPITAL PARTNERS GP, L.L.C. 2,432,700$99,522,0000.24%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders